A new blood sugar test could provide a life-saving diagnosis for men who do not yet exhibit symptoms of prostate cancer.
To assist create a test for early detection, research at Swansea University is examining the blood of persons who have the condition.
In the UK, one in eight men may develop prostate cancer, and the number of new cases has increased in the past three years.
It may save lives, according to Simon Gammon, 62, who has been given a terminal prognosis.
According to Prostate Cancer UK, Wales is one of the UK’s worst-affected regions for late referrals and diagnoses of prostate cancer.
In Wales, one in five men who have the condition receives a diagnosis that is too late for treatment. This percentage is one in eight in London.
Much more at risk are older males, men of color, and those with a family history of the illness. Swansea University’s initiative has received funding from Prostate Cancer UK as part of the organization’s Research Innovation Awards (RIAs), a £3 million investment made by seven UK institutions in the most cutting-edge treatments for prostate cancer.
Since that it frequently presents with no symptoms at first, it is hoped that it will result in testing that is more accurate and earlier diagnoses.
More than £400,000 has been given to Dr. Jason Webber for research into the development of a novel non-invasive blood test.
In order to create tests to estimate a man’s chance of having prostate cancer and how likely it is to spread, the study will look into specific sugars detected in the bloodstream of men with the condition.
Prostate cancer turns into incurable when it spreads outside of the prostate.
According to Dr. Webber, it might help eliminate intrusive examinations.
“The blood sugars we’re focusing on aren’t the same as the sugar or glucose, we consume in food and drinks. These sugars are found on the surface of ‘extracellular vesicles’, small packages released by prostate cancer cells into the bloodstream, which trick and invade healthy cells, spreading cancer around the body,” he said.
“Early diagnosis is key to treating prostate cancer and it is certainly one of the things that have become more apparent over recent years.”
He claimed that Wales, whose early detection rates are lower than in other regions of the UK, could benefit most from this.
“By identifying those patients with the aggressive disease early on we hope that they can be targeted with the correct treatment allowing the disease to be treated,” he said.
-All Rights Reserved-
Permission to use any material, including text, still photograph, audio and video from this site is granted subject to permission being formally sought and, if granted, appropriate credit must duly be given to The News Room as the source.
Stay connected, get exclusive updates, and be the first to know about all the exciting things happening. Whether you’re looking for insights, tips, or just want to be part of an amazing community, our WhatsApp group is the place to be!
👉 Don’t miss out. Click the link and be part of something awesome! 🚀
